SciDev Ltd Overview
SciDev is an Australian micro-cap water-treatment technology and specialty-chemistry company. It combines three things: proprietary chemistry (MaxiFlox®, CatChek®, xSlik®), engineered treatment plants (including FluoroFIX®/RegenIX® PFAS systems and Build-Own-Operate fleets), and data/optimisation tools (Hydra-IQ™, OptiFlox®). It serves mining, infrastructure/tunnelling, US onshore oil and gas, and, newly, hyperscale data centres.
The company grew revenue from A$42.5m in FY21 to a record A$109.2m in FY24. It then contracted to A$85.5m in FY26 after losing a high-margin US friction-reducer contract and exiting loss-making US/UK water operations.
A June 2026 strategic review, led by new CEO Todd Scott, reset the business around an "integrated water solutions platform" focused on Mining, Data Centres and Energy. The stated priorities are recurring revenue (38% of FY26 revenue), capital discipline and cross-selling into a tier-one installed base.
SciDev now trades at roughly 0.65× book value with net cash. It is a turnaround story whose credibility depends on FY27 delivery.
Company's own description
In its FY26 results (27 August 2026), SciDev describes itself as a leading water-treatment technology company serving the mining, data centre and energy industries.
The FY26 Appendix 4E defines its two operating segments as follows:
Water Solutions: Specialised water treatment and remediation technologies, plus process chemistries for mining and construction. These remove contaminants from groundwater, surface water and industrial liquid waste so the water can be recycled or safely discharged.
Energy Services: Develops, manufactures and supplies specialty oilfield and production chemistries that improve efficiency, reduce waste and cut water consumption in the energy industry.
Earlier descriptions (FY24 Annual Report) framed SciDev as an "environmental solutions" company for water-intensive industries.
Business model and revenue model
SciDev earns revenue through five channels:
-
Product sales (point-in-time).
-
Specialty chemistry sold to oilfield service companies and E&P operators in the US: CatChek® clay control, xSlik® premium friction reducer, and commodity-grade friction reducers.
-
Flocculants/coagulants sold to Australian mining and tunnelling clients: MaxiFlox®, MaxiDry™.
-
Goods transferred at a point in time were A$63.5m in FY26 (74% of customer revenue), down from A$85.6m in FY25 (83%) (FY26 Appendix 4E, Note 3).
-
-
Design & Construct (D&C) contracts (over time). Water treatment plants built for construction contractors and mine-rehabilitation projects. The largest is the A$19.5m Rum Jungle groundwater treatment plant for McMahon Services in the Northern Territory.
-
Build-Own-Operate (BOO) and Operations & Maintenance (O&M) services (over time). Redeployable PFAS and other treatment plants run under service contracts. For example, a ~A$2m Ventia BOO PFAS plant in Victoria and a multi-year PFAS treatment contract with a blue-chip mining client.
-
Technical services and dose-control/monitoring hardware.
-
OptiFlox® dosing control (bundled with MaxiFlox® in the Newmont contract).
-
Hydra-IQ™ water-quality monitoring stations (e.g., 30 stations across Western Australian mines, FY24).
-
-
Consulting/design. New in FY27: data-centre design, consulting and embedded engineering (~A$0.5m expected in 1H FY27).
Services transferred over time rose to A$21.9m in FY26 (26% of customer revenue) from A$17.7m in FY25. This reflects the shift toward project and O&M revenue.
There is no material subscription or licensing revenue. A small rental income line exists (A$0.15m FY26).
Recurring revenue. SciDev reported recurring revenue of 38% of FY26 revenue, up from 30% in FY25. Including CatChek® sales (short-term but repeat contracts), the figure would be 59%.
Definitional discrepancy: The 1H FY26 release reported recurring revenue of 54% using the broader definition that includes CatChek®. The full-year headline uses the narrower definition. Investors should compare like-for-like.
Value-chain position
SciDev sits mid-stream:
Upstream: It sources polymer feedstock and chemicals, partly through the Nuoer Group. A 50% joint venture, Nuoer SciDev JV Pte Ltd (Singapore), provides "secured feedstock" for MaxiFlox® (Investor Day, 17 June 2026). SciDev blends, formulates and applies chemistry rather than operating large-scale polymer production.
Downstream: It supplies field application, engineering design, plant construction, operations and data monitoring.
Differentiation: The company argues its edge lies in application know-how and proprietary formulations, not commodity volume.
Customer types and end-markets
| End-market | Customer types | FY26 share of revenue (company) |
|---|---|---|
| Mining | Gold/copper, mineral sands and legacy-mine remediation clients (Newmont Boddington, Iluka, a blue-chip WA miner, NT Government via McMahon Services) | 43% |
| Energy (US onshore oil & gas; Beetaloo Basin, Australia emerging) | Oilfield service companies (including a tier-one provider under a new MSA) and E&P operators in the Permian, Eagle Ford, Haynesville and Utah basins | 43% |
| Infrastructure / construction | Tier-1 tunnelling contractors (e.g., Acciona; contractors on Sydney Metro West and Western Harbour Tunnel), utilities/facility managers (Ventia), waste operators (Cleanaway New Chum landfill) | 14% |
| Data centres (new FY27) | Two of Australia's largest hyperscale operators/developers | ~0% (first revenue in 1H FY27) |
Source: FY26 results (Kalkine summary of FY26 announcement); company announcements.
By revenue mix (FY26): Water Solutions 56%, Energy Services 43%, exited international water 1%.
Customer concentration (FY24 Annual Report, Note 4):
-
One Chemical Services client contributed A$45.4m in FY24 (≈42% of group revenue), up from A$30.8m in FY23.
-
One Water Technologies client contributed A$6.5m in FY24.
The large Energy Services client concentration was the transmission mechanism for the FY26 xSlik® contract loss.
Independent characterisation
SciDev is best understood as two businesses under one listed roof:
-
A cyclical, concentrated US oilfield-chemicals distributor-formulator (Energy Services, acquired via Highland Fluid Technology in 2020). It has one genuinely differentiated product (CatChek®) and exposure to frac-spread cycles and customer purchasing decisions.
-
An Australian water-solutions contractor and chemistry supplier (Water Solutions). It is building recurring revenue via multi-year mining chemistry contracts, O&M and monitoring, and is now growing with a regulatory tailwind (PFAS, mine rehabilitation) plus an optional new vertical (data centres).
The FY26 reset effectively admits that the earlier global PFAS expansion was premature. The strategic review found that strong Energy Services earnings had masked a rising cost base and sub-scale entry into too many markets.
Strategy
Stated strategy (Investor Day, 17 June 2026; FY26 results, 27 August 2026)
Core theme. SciDev is resetting around an integrated water solutions platform that spans engineering, chemistry and data. It will target markets where it believes it has a genuine right to win: Mining, Data Centres and Energy (with Utilities & Infrastructure also cited as a core market). CEO Todd Scott acknowledged that the past year had cost the company shareholder trust.
Strategic review diagnosis. The review found that past cyclical strength in Energy Services had masked a rising cost base and poor capital allocation, including sub-scale entry into too many markets.
Corrective disciplines adopted:
-
Business cases, hurdle rates and stage-gating for all capital decisions.
-
Risk-weighted forecasting aligned to outlook visibility.
-
Priority protection of key accounts, with added resourcing for new business development.
-
Focus on core markets where SciDev can build scale.
Platform architecture (four layers):
-
Engineering
-
High-value chemistry
-
Data monitoring (Hydra-IQ™, OptiFlox®)
-
AI-driven optimisation (on the roadmap)
The first three layers are in market today.
Market sizing (company estimates):
-
~A$4bn of addressable value across target industries in home markets.
-
A$30–45bn globally.
-
Water Solutions markets alone: ~A$2.2bn today, forecast to exceed A$6bn by 2040.
FY27 priorities (FY26 results):
-
Expand engineering, chemistry and data services across the established mining client base.
-
Establish a meaningful water-solutions position in data centres.
-
Rebuild Energy Services growth through tier-one service-provider partnerships and expansion in the highest-demand CatChek® basins.
Initiatives announced in the last 24 months
| Initiative | Date | Detail | Targets / status |
|---|---|---|---|
| International expansion (Europe, US PFAS) | FY24–FY25 | Pilot plants, VP North America, Sweden/UK contracts | Reversed in 2H FY26 |
| Channel-partner model for international water | Announced 25 Feb 2026; completed 2H FY26 | Exit of US/UK direct operations | ~A$3m in annualised costs removed from FY27 |
| Corporate cost reduction | 1H–2H FY26 | Headcount and administration cuts | Corporate costs −19% YoY in 1H FY26 (maintained); full-year corporate EBITDA loss −33%; group cost base ~A$4m lower vs FY25 |
| Capex and working-capital discipline | FY26 | Lower capex (A$0.6m vs A$2.1m) | Capital discipline framework presented at Investor Day |
| Energy Services diversification | FY26 | MSA and first revenue with a tier-one oilfield service provider; Permian expansion; Beetaloo Basin (Australia) discussions | Customer concentration reduction (in progress) |
| New product development, Energy | FY26 | EnFlow (EOR), CatChek® variants, high-suspension slurries | Pre-commercial |
| Data-centre entry | Investor Day 2026; first contracts 5 Aug 2026 | HydraCool reuse platform; team with 40+ European data-centre water projects and 10 years' experience | Design consulting revenue in FY27 (~A$0.5m in 1H FY27); potential construction contracts in FY28 |
| Data & optimisation commercialisation | FY27 | Commercialise Hydra-IQ™ and OptiFlox®; aggregate datasets | FY27 objective |
| Cross-selling to mining installed base | FY27 | Sales function build-out | Newmont Boddington win; several contracts in late trial/negotiation, including via the Nuoer JV |
| Recurring-revenue growth | Ongoing | Multi-year process chemistry, O&M, CatChek® | 30% (FY25) → 38% (FY26) narrow definition; no numeric target set |
Sustainability / ESG commitments
The company has developed an ESG framework, a refreshed purpose statement and values (FY23). No quantified emissions or ESG targets were found in the sources reviewed.
Management guidance and targets
No formal FY27 guidance: Management said it would replace forecasts with delivery.
Disclosed forward indicators (17 June 2026): - Firm FY27 order book of ~A$39m in revenue.
- Submitted open tender pipeline of ~A$115m.
Medium-term financial targets: None publicly quantified.
Products & Services
Pricing is not publicly disclosed for any product. All products are sold on project, contract or per-volume terms.
Water Solutions — Process Chemistry
| Product / offering | Description & capabilities | Target customer | Launch / latest | Flagship evidence |
|---|---|---|---|---|
| MaxiFlox® | Proprietary flocculant chemistry for solids-liquid separation (tailings, thickening, dewatering). Supported by feedstock secured through the Nuoer JV. | Gold/copper and mineral-sands miners; resellers in Turkey and Mexico | Long-standing; current-generation date not disclosed | Newmont Boddington (~A$6.0m over 3 years from 1H FY27); Iluka; Thunderbird mineral sands (~A$7.0m over 2 years) |
| MaxiDry™ | Chemistry and services for tunnelling spoil and slurry management (dewatering, spoil conditioning). | Tier-1 tunnelling contractors | — | NSW tunnelling contract awarded Q2 FY24; "large-scale tunnelling infrastructure projects" drove record FY26 Process Chemistry revenue |
| OptiFlox® | Automated dose-control and optimisation technology paired with flocculant supply. Part of the "data & optimisation" layer. | Mining processing plants | Commercialisation priority for FY27 | Bundled in the Newmont Boddington contract |
| Technical services | On-site application engineering and process optimisation. | Mining and construction | — | Embedded in multi-year mining contract renewals |
Water Solutions — Water Technologies (APAC)
| Product / offering | Description & capabilities | Target customer | Launch / latest | Flagship evidence |
|---|---|---|---|---|
| FluoroFIX® / FluorofIX™ | Proprietary PFAS treatment technology (adsorbent/media-based process) used in BOO and D&C plants. Pilot plants built in Europe and North America (FY24). | Defence, mining, landfill, utilities, construction | Pilot plants FY24; commercial use since at least FY21 | >1bn litres of PFAS-contaminated water treated for a blue-chip miner (A$4.7m two-year extension, FY24); Ventia BOO (~A$2m) |
| RegenIX™ / RegenIX® | Regenerable ion-exchange PFAS concentration/destruction-support process; submitted to the US DoD ESTCP programme (FY24). | Defence, utilities, industrial | — | Independent validation of FluorofIX and RegenIX cited (Simply Wall St narrative, Dec 2025) |
| Build-Own-Operate (BOO) treatment fleet | Redeployable treatment plants for short-duration contaminated water work; O&M contracts. | Utilities, infrastructure, mine sites | Ongoing | 7–9 concurrent PFAS projects in FY24 quarters (e.g., Q4 FY24: 7 projects, A$3.8m revenue) |
| Design & Construct (D&C) water treatment plants | Permanent multi-stage treatment plants (AMD, radiological, metals). | Mine-rehabilitation owners, tunnelling contractors | Ongoing | Rum Jungle 30 L/s plant (A$19.5m; operational target 4 Sep 2026; option for 2-year O&M; potential 15-year O&M); Western Harbour Tunnel WTP (A$4.75m); Acciona D&C (A$4.6m); New Chum landfill (Cleanaway) |
| Hydra-IQ™ | Water-quality monitoring stations and data platform; sales grew in FY26. | Mine operators | FY24 deployments; commercialisation priority FY27 | 30 monitoring stations for a blue-chip WA miner (FY24) |
| HydraCool | Purpose-built water reuse platform for data-centre cooling water. | Hyperscale data-centre operators | Introduced at Investor Day, June 2026 | First design/consulting contracts with two hyperscalers (Aug 2026) |
Energy Services (US-based; Beetaloo Basin, Australia, emerging)
| Product / offering | Description & capabilities | Target customer | Launch / latest | Flagship evidence |
|---|---|---|---|---|
| CatChek® (incl. CatChek™ 12S and new variants) | Clay control/stabilisation chemistry for hydraulic fracturing. Company states it is independently verified across 3,000+ wells to deliver higher BOE uplift and less wastewater; ~2% market share. | E&P operators and oilfield service companies | Ongoing; new variants in development (FY26) | Sales +51.5% in FY24 and +46% in FY25; 51% of Energy Services revenue in FY26 (up from 41%); clients buying CatChek® +75% YoY in 1H FY26 |
| xSlik® | Premium friction-reducer chemistry for slickwater fracs using recycled water. Was among Energy Services' highest-margin products. | Oilfield service companies | — | Key contract lost in FY26: ~A$8.6m lower EBITDA vs FY25 at group level; ~A$5m of the segment decline |
| Commodity friction reducers | Standard-grade friction reducers. | Oilfield service companies | — | Faced intensified price competition in FY26 |
| EnFlow (in development) | Enhanced Oil Recovery chemistry. | E&P operators | Under development (FY26) | Not yet commercial |
| High-suspension slurries (advanced delivery systems) | Concentrated delivery formats for chemistry. | Service companies | Under development (FY26) | Not yet commercial |
| TrueMud™ / fluid technology services (HFT legacy) | Patent-pending lightweight drilling-fluid mixer and formulation services. | Majors / large operators | 2020–21 | ExxonMobil purchase orders (2020; extension Feb 2021). Current activity not disclosed. |
| R&D contract services | Formulation R&D. | Qatar Shell GTL Ltd | Renewed FY24 | Contract renewal disclosed in FY24 Annual Report |
Exited / restructured offerings
International Water Technologies (US, UK, Europe)
-
Direct PFAS and industrial-water operations were closed in 2H FY26. The business moved to a channel-partner sales model.
-
FY26: revenue A$0.5m, underlying EBITDA loss A$2.1m.
-
1H FY26 loss alone was A$1.5m.
-
First Swedish and UK contracts had been secured in 1H FY25.
Financial Narrative
Sources by year:
-
FY2022: FY24 Annual Report remuneration KPM table; FY22 opening balances in the FY24 statement of changes in equity
-
FY2023–FY2024: FY24 Annual Financial Report
-
FY2025–FY2026: FY26 Appendix 4E (FY25 comparatives as restated)
-
FY2026 figures are unaudited as at 27 August 2026.
FY2021 reference points (FY24 Annual Report KPM table): revenue A$42.5m; NPAT A$3.45m; EPS 2.26c.
Income statement
Notes on the income statement:
FY24 revenue: The CEO's quote and the Q4 update cite A$109.3m; the statutory figure is A$109.236m.
FY22 EBITDA: Full-year FY22 EBITDA was not available in the sources reviewed. 1H FY22 EBITDA was −A$0.4m.
Revenue CAGR (analyst calculation):
-
FY22–FY26 (4 years): 11.4%
-
FY21–FY26 (5 years): 15.0%
-
FY21–FY24 peak (3 years): 37.0%
FY26 significant items (FY26 Appendix 4E) — these bridge underlying EBITDA (A$3.60m) to reported EBITDA (−A$1.10m) for EBITDA-level items:
Effective tax anomaly in FY25. FY25 tax expense was A$2.33m on a pre-tax profit of A$1.46m, turning a pre-tax profit into a net loss. The structural cause is that overseas (US) profits are taxed while Australian losses are not recognised. FY24 disclosed A$55.2m of unused tax losses without a recognised deferred tax asset (potential benefit A$16.4m). This is a latent value item if Australian profitability is sustained.
Balance sheet
Notes on the balance sheet:
-
The FY24 interest-bearing liability of A$2.32m was the deferred Haldon vendor payable (12% interest, related party). FY25–FY26 debt is Westpac bank debt.
-
Goodwill at 30 June 2026 is allocated across three cash-generating units: Energy Services A$7.5m, Process Chemistry A$3.0m, Water Technologies A$10.1m.
Cash flow
Notes on cash flow:
- SciDev reports "underlying operating cash flow" of A$6.0m for FY26. Statutory operating cash flow was A$3.6m. The difference reflects company adjustments (e.g., restructuring cash and tax refunds).
Half-year pattern conflict: The FY26 announcement table shows underlying OCF of A$2.9m (1H) and A$6.0m (2H). The text describes A$6.0m as the full-year total. This is internally inconsistent in the released document and should be confirmed against the audited Annual Report.
Ratios (analyst calculations, year-end balances)
Note: The FY24 cash conversion cycle excludes A$4.9m of contract assets. Including them, FY24 DSO is about 41 days and the CCC about 5 days.
Commentary on trends, inflections and drivers
Growth phase (FY21–FY24). Revenue rose from A$42.5m to A$109.2m. Three acquisitions drove this:
-
HFT (2020) took the US oilfield business from zero to a majority of revenue: US revenue was A$61.2m in FY24.
-
Haldon (2021) built the Water Technologies/PFAS platform.
-
Organic growth came from MaxiFlox® mining contracts and tunnelling projects.
FY24 was the profitability peak: underlying EBITDA A$8.8m (8.1% margin), NPAT A$2.2m, operating cash flow A$6.5m. Management attributed the margin gain to moving US customers from commodity to proprietary products (CatChek®, xSlik®).
Stall (FY25). Revenue fell 5% to A$103.4m:
-
Water Technologies dropped 26% because domestic contracts were delayed.
-
Management deliberately de-emphasised commodity chemistry.
-
Underlying EBITDA fell to A$7.1m as SciDev invested in international sales, engineering and project governance.
-
Water Technologies also had projects needing costly rework (later reflected in the FY26 "ISO asset rectification" item).
-
Tax leakage produced a net loss despite a pre-tax profit.
Break (FY26). Revenue fell 17% to A$85.5m. Underlying EBITDA halved to A$3.6m. Two causes explain the entire EBITDA variance:
-
The xSlik® contract loss (−A$8.6m EBITDA), on top of weak US frac activity.
-
International water losses (−A$2.1m).
Offsets were record Water Solutions EBITDA (A$4.2m, +A$3.6m) and a 33% cut in corporate costs (+A$1.6m). Statutory NPAT was −A$5.8m, including the A$2.85m write-off of Haldon customer contracts and IP.
Second-half inflection. 2H FY26 underlying EBITDA was A$2.5m on revenue of A$37.6m (6.7% margin), versus A$1.1m on A$47.9m in 1H (2.3%). This suggests the cost-out is real. The 2H margin is also flattered by Rum Jungle construction revenue, which is non-recurring at that scale.
Balance sheet. The balance sheet is conservative: net cash in every year, A$13.8m total liquidity at 30 June 2026, and debt-to-equity below 0.15×. The company has never paid a dividend and does not buy back shares. Working capital swings are large relative to EBITDA. Net cash fell to A$1.4m at 31 May 2026 because of Rum Jungle working capital, then recovered to A$6.8m by 30 June 2026.
Guidance credibility. This is the central financial issue. FY26 revenue guidance went from A$120–140m (August 2025) to A$100–110m (February 2026) to A$82–87m (April 2026). Actual revenue of A$85.5m landed in the final range. Management has since said it will stop giving formal forecasts. No FY27 guidance was issued.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (AUD Mn) | 55.6 | 89.8 | 109.2 | 103.4 | 85.5 |
Revenue growth YoY (%) | 30.7 | 61.6 | 21.6 | -5.4 | -17.3 |
Company-reported gross margin (%) | — | — | — | 28 | 26 |
Revenue less materials & consumables (AUD Mn), analyst calc. | — | 24.3 | 34.1 | 34.5 | 27.3 |
Materials margin (%), analyst calc. | — | 27.0 | 31.2 | 33.4 | 32.0 |
Employee benefits expense (AUD Mn) | — | 12.6 | 16.1 | 18.0 | 16.9 |
Reported EBITDA (AUD Mn) | — | 3.92 | 8.84 | 6.19 | -1.10 |
Underlying / adjusted EBITDA (AUD Mn) | — | 4.08 | 8.84 | 7.13 | 3.60 |
Depreciation & amortisation (AUD Mn) | — | 3.51 | 4.09 | 4.17 | 4.21 |
EBIT (AUD Mn), PBT plus finance costs | — | 0.41 | 4.75 | 2.02 | -5.31 |
Finance costs (AUD Mn) | — | 0.63 | 0.65 | 0.57 | 0.51 |
Profit before tax (AUD Mn) | — | -0.22 | 4.10 | 1.46 | -5.82 |
Income tax expense (AUD Mn), benefit negative | — | 0.12 | 1.93 | 2.33 | -0.05 |
Net profit after tax (AUD Mn) | -0.62 | -0.34 | 2.18 | -0.88 | -5.77 |
Basic EPS (A$ cents) | -0.35 | -0.18 | 1.15 | -0.5 | -3.0 |
Diluted EPS (A$ cents) | — | -0.18 | 1.13 | -0.5 | -3.0 |
Dividends per share (A$ cents) | 0 | 0 | 0 | 0 | 0 |
Underlying EBITDA margin (%) | — | 4.5 | 8.1 | 6.9 | 4.2 |
EBIT margin (%) | — | 0.5 | 4.4 | 2.0 | -6.2 |
Net margin (%) | -1.1 | -0.4 | 2.0 | -0.8 | -6.7 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansKey Financials
| Item (AUD Mn) | FY2025 | FY2026 |
|---|---|---|
Impairment of intangible assets, Haldon (AUD Mn) | 0 | 2.845 |
Restructuring incl. redundancies (AUD Mn) | 0 | 1.030 |
ISO asset rectification (AUD Mn) | 0 | 0.637 |
UK subsidiary wind-down costs (AUD Mn) | 0 | 0.190 |
Transaction costs incl. due diligence (AUD Mn) | 0.938 | 0 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | — | 67.4 | 72.0 | 75.2 | 61.8 |
Cash & equivalents (AUD Mn) | 14.1 | 7.7 | 9.4 | 9.7 | 8.6 |
Trade & other receivables, current (AUD Mn) | — | 7.5 | 7.4 | 15.0 | 12.0 |
Contract assets, current (AUD Mn) | — | 0.6 | 4.9 | 0.6 | 0.3 |
Inventories (AUD Mn) | — | 6.9 | 7.5 | 7.4 | 5.9 |
Goodwill (AUD Mn) | 20.6 | 20.9 | 20.8 | 21.0 | 20.6 |
Goodwill & intangibles total (AUD Mn) | 25.9 | 25.6 | 25.0 | 24.7 | 21.0 |
Bank / interest-bearing debt, current (AUD Mn) | — | 0 | 2.32 | 1.53 | 0.53 |
Bank / interest-bearing debt, non-current (AUD Mn) | — | 0 | 0 | 1.81 | 1.29 |
Lease liabilities, total (AUD Mn) | — | 3.48 | 2.81 | 2.92 | 1.74 |
Total debt incl. leases (AUD Mn) | — | 3.48 | 5.13 | 6.26 | 3.55 |
Net cash, company definition (AUD Mn), cash less bank loans | — | 7.73 | 7.11 | 6.34 | 6.75 |
Net cash incl. leases (AUD Mn), analyst calc. | — | 4.25 | 4.30 | 3.42 | 5.01 |
Total equity (AUD Mn) | 48.8 | 48.0 | 50.2 | 50.1 | 43.0 |
Net working capital (AUD Mn) | — | 6.6 | 9.9 | 12.1 | 11.6 |
NTA per share (A$ cents) | — | 11.80 | 13.27 | 13.31 | 11.56 |
Cash Flow
| Metric | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Operating cash flow, statutory (AUD Mn) | 4.81 | 6.48 | 2.87 | 3.61 |
Capex, PP&E plus intangibles (AUD Mn) | 4.29 | 2.07 | 2.12 | 0.59 |
Free cash flow, OCF less capex (AUD Mn) | 0.52 | 4.42 | 0.75 | 3.02 |
Lease principal payments (AUD Mn) | 3.01 | 1.07 | 1.29 | 1.35 |
FCF after leases (AUD Mn) | -2.49 | 3.35 | -0.55 | 1.66 |
Business acquisition payments (AUD Mn) | 3.62 | 1.59 | 0 | 0 |
Related-party loan repayment, Haldon (AUD Mn) | 0 | 0 | 2.38 | 0 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 |
Net bank borrowing / (repayment) (AUD Mn) | 0 | 0 | 3.50 | -1.60 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
ROE (%) | -0.7 | 4.3 | -1.8 | -13.4 |
ROA (%) | -0.5 | 3.0 | -1.2 | -9.3 |
ROIC (%), NOPAT at 30% tax / (equity + debt incl. leases − cash) | 0.7 | 7.2 | 3.0 | -9.8 |
Current ratio (x) | 1.39 | 1.49 | 1.56 | 1.70 |
Debt-to-equity incl. leases (x) | 0.07 | 0.10 | 0.13 | 0.08 |
Net debt / underlying EBITDA (x), negative = net cash | -1.04 | -0.49 | -0.48 | -1.39 |
Interest coverage, underlying EBITDA / finance costs (x) | 6.5 | 13.6 | 12.6 | 7.1 |
Asset turnover (x) | 1.33 | 1.52 | 1.37 | 1.38 |
DSO, trade receivables (days) | 30 | 25 | 53 | 51 |
DIO, inventory / materials cost (days) | 39 | 37 | 39 | 37 |
DPO, trade payables / materials cost (days) | 62 | 73 | 69 | 58 |
Cash conversion cycle (days) | 7 | -11 | 23 | 30 |
Revenue by Region
| Region | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Australia revenue (AUD Mn) | 31.9 | 45.3 | 41.7 | 46.0 |
United States revenue (AUD Mn) | 55.8 | 61.2 | 60.7 | 37.1 |
Asia revenue (AUD Mn) | 1.04 | 0.57 | 0.39 | 0.83 |
Other revenue (AUD Mn), incl. Europe/UK and resellers | 1.01 | 1.96 | 0.49 | 1.41 |
Total customer revenue (AUD Mn) | 89.7 | 109.1 | 103.2 | 85.4 |
Region Margins & Growth (%) and Revenue by Region (%)
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Australia YoY growth (%) | 42.0 | -8.1 | 10.5 |
United States YoY growth (%) | 9.8 | -0.9 | -38.8 |
Australia share of revenue (%) | 41.6 | 40.4 | 53.9 |
United States share of revenue (%) | 56.1 | 58.8 | 43.5 |
Share Price
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Share price at 30 June (AUD) | 0.58 | 0.85 | 0.18 | 0.33 | 0.37 |
Share Price & Returns
| Period | Approximate return | Basis |
|---|---|---|
1-year | −55% | ~A$0.33 (Oct/Nov 2025) to A$0.148 |
3-year | −50% to −55% | Roughly A$0.30–0.33 (Oct 2023) to A$0.148; Oct 2023 price not precisely verified |
5-year | about −80% | — |
Valuation Snapshot
| Metric | Value |
|---|---|
Market capitalisation | A$28.1m |
Enterprise value (market cap + bank debt A$1.81m + leases A$1.74m − cash A$8.57m) | A$23.1m |
P/E (FY26) | Not meaningful (loss) |
EV / underlying EBITDA (FY26) | 6.4× |
EV / 2H FY26 annualised underlying EBITDA (A$5.0m) | 4.6× |
EV / Sales (FY26) | 0.27× |
P/B (equity A$42.95m) | 0.65× |
P/NTA (11.56c) | 1.28× |
Capital Markets
| Item | Detail |
|---|---|
Dividend history | No dividends paid, recommended or declared in FY22–FY26 (FY24 Annual Report; FY26 Appendix 4E) |
Dividend policy | None stated; capital directed to organic growth |
Buybacks | None authorised or executed |
Credit ratings | No Moody's / S&P / Fitch ratings (unrated) |
Debt facilities | Westpac A$10m package (Aug 2024): A$5m revolver, A$2m equipment finance, up to A$3m amortising. A$7.0m unutilised at 30 Jun 2026. |
Debt maturity profile (30 Jun 2026) | Current interest-bearing A$0.53m; non-current A$1.29m; leases A$0.74m current and A$1.00m non-current. Detailed maturity ladder not disclosed in the Appendix 4E. |
Analyst Conclusions
Management guidance and forward indicators
No FY27 revenue or EBITDA guidance: Management has explicitly moved from forecasts to delivery-based communication.
Disclosed forward indicators: - FY27 firm order book ~A$39m (as at June 2026).
-
Submitted tender pipeline ~A$115m.
-
Newmont Boddington ~A$2m a year from 1H FY27.
-
Data-centre consulting ~A$0.5m in 1H FY27.
-
Remaining ~50% of Rum Jungle revenue (~A$9–10m) recognised in FY27.
-
~A$3m of annualised international costs removed from FY27.
Consensus: Not available.
Analyst illustration (not a forecast). If Energy Services stabilises at the FY26 run-rate, Water Solutions sustains its 2H FY26 margin, and corporate costs hold at the FY26 exit level, FY27 underlying EBITDA could plausibly exceed FY26's A$3.6m. This depends on replacing Rum Jungle construction revenue in FY28. This is an analytical scenario, not company guidance.
Bull case
-
Leaner cost base with operating leverage. About A$4m of costs removed, and a 6.7% underlying EBITDA margin in 2H FY26 despite lower revenue. Any Energy Services recovery or Water Solutions growth flows through at high incremental margin.
-
Recurring-revenue quality improving. Recurring revenue rose from 30% to 38%. Multi-year contracts (Newmont; potential Rum Jungle 15-year O&M) support a re-rating toward water-infrastructure multiples.
-
Asymmetric valuation. EV of ~A$23m against A$85.5m revenue (0.27×) and 0.65× book. Net cash, about A$16m of potential tax benefit from unrecognised losses, and new optionality (data centres, CatChek® via a tier-one oilfield service channel, Beetaloo Basin).
Bear case
-
Credibility and forecasting. FY26 guidance was cut by about 35% from midpoint to actual. The CEO and CFO changed, and the auditor changed. The market may refuse to pay for pipeline until several clean halves are delivered.
-
Energy Services remains concentrated and cyclical. Commodity friction-reducer competition persists. CatChek® is ~51% of a shrinking segment. Another customer loss would be material against a A$3.6m EBITDA base.
-
Lumpy Water Solutions earnings. The FY26 Water Technologies APAC profit was largely Rum Jungle construction. Without a comparable D&C win, FY28 faces a revenue hole. Data centres are unproven and are unlikely to deliver construction revenue before FY28.
Key catalysts and monitorables (next 12 months)
-
2026 AGM (late 2026): board composition, CFO appointment status, remuneration votes.
-
Rum Jungle commissioning and handover (target September 2026), and award of the O&M extension.
-
Appointment of a permanent CFO.
-
1H FY27 results (expected around February 2027): first test of the reset, including 1H underlying EBITDA versus A$1.1m in 1H FY26.
-
Conversion of the ~A$115m tender pipeline; additional mining chemistry contracts (including through the Nuoer JV).
-
Data-centre progression from consulting to construction-phase awards.
-
US frac spread counts; CatChek® volumes through the tier-one oilfield service MSA; Beetaloo Basin supply decision.
-
Working-capital behaviour (net cash trajectory) and any capital-raising signals.
-
Substantial-holder movements (Mercer 8.82%) and director trading.
Analyst verdict
SciDev enters FY27 as a smaller but cleaner business than the one that reported record results two years ago. The FY26 numbers are poor in absolute terms: revenue down 17%, underlying EBITDA halved, a statutory loss of A$5.8m. Underneath them, however, are two encouraging facts.
First, the Australian Water Solutions franchise had its best year: A$4.2m of underlying EBITDA on 13% revenue growth, supported by tier-one mining, tunnelling and remediation clients.
Second, management acted decisively on what failed. It exited sub-scale international water operations, cut corporate costs by a third, reduced capex sharply and rebuilt net cash to A$6.8m. The second-half margin recovery to 6.7% suggests these actions are real.
The investment debate now turns less on strategy, which is coherent, than on execution and visibility. The integrated engineering-chemistry-data platform makes sense for a company whose clients already buy two of the three layers. The danger is that SciDev's earnings remain hostage to two volatile pillars: one US oilfield business still exposed to customer concentration and frac cycles, and a project-heavy water business that must replace Rum Jungle's construction revenue.
Management's refusal to guide is defensible after two downgrades. It also means investors must underwrite the turnaround from the order book (~A$39m) and pipeline (~A$115m) alone.
At about 0.27× EV/Sales, 0.65× book, with net cash and a potentially valuable unrecognised tax shield, the market is pricing SciDev close to a no-growth, ongoing-disappointment scenario. That creates asymmetric upside if 1H FY27 confirms the 2H FY26 run-rate, Rum Jungle transitions into long-term O&M, and either data centres or CatChek® channel partnerships produce visible revenue.
Verdict: a speculative, execution-dependent turnaround. The 1H FY27 result is the critical proof point. Until then, conviction should stay modest despite the apparent valuation support.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles / education |
|---|---|---|---|
Todd Scott | Chief Executive Officer | CEO since 26 May 2026; CFO from 27 Oct 2025 | Group VP Investor Relations, Sims Ltd; equity research analyst at ABN AMRO Equities (Australia) and RBS Equities (Australia) |
John Gardiner | Interim Chief Financial Officer | Since 26 May 2026 | — |
Heath L. Roberts | Company Secretary & General Counsel | Engaged since 1 Mar 2017 | Commercial solicitor; 21+ years of listed-company experience; Dip Law (SAB), Grad Dip Legal Practice (UTS) |
“—” = not publicly disclosed.
Board of Directors
| Name | Role | Appointed | Background | Independence |
|---|---|---|---|---|
Michael (Mike) Utsler | Non-executive Chair | NED 1 Mar 2024; Chair 1 Apr 2025 | 40+ years in energy (Amoco, BP incl. President of the Gulf Coast Restoration Organisation, SVP BP Alaska Exploration; Woodside; New Fortress Energy); ex-CEO/Exec Chair Otto Energy; NED Santos Ltd (from May 2022); ex-director Oil Search. BSc (Petroleum Eng), GAICD. Age 69 (MarketScreener). | Independent |
Dan O'Toole | Non-executive Director | 3 Feb 2021 | 36+ years in engineering consulting; ex-CEO Pitt & Sherry; executive at Coffey International; co-founder of Viotel. BEng (Hons), FIEAust. | Independent |
Johannes Risseeuw | Non-executive Director | 1 Apr 2025 | Experienced director in corporate strategy, governance, commercial matters and M&A. | Independent (presumed) |
Jon Gourlay | Non-executive Director (status unclear) | 28 May 2019 | Chartered accountant; ex-Newcrest, Glencore Zinc; Principal Advisor to the Treasurer of Tasmania. BCom, CA, GAICD. | Independent |
Board of Directors by Name / Role
| Name / role (FY24) | Salary & fees (AUD) | Bonus (AUD) | Superannuation (AUD) | Share-based (AUD) | Total (AUD) |
|---|---|---|---|---|---|
Seán Halpin, CEO | 360,500 | 93,348 | 27,399 | 58,333 | 539,580 |
Anna Hooper, CFO | 336,225 | 55,870 | 27,399 | 41,666 | 461,160 |
Heath Roberts, CoSec & GC | 205,000 | 0 | 0 | 0 | 205,000 |
Vaughan Busby, Chair | 95,000 | 0 | 10,450 | 0 | 105,450 |
Simone Watt, NED | 60,000 | 0 | 6,600 | 0 | 66,600 |
Jon Gourlay, NED | 60,000 | 0 | 6,600 | 0 | 66,600 |
Dan O'Toole, NED | 60,000 | 0 | 6,600 | 0 | 66,600 |
Michael Utsler, NED (from 1 Mar 2024) | 20,000 | 0 | 2,200 | 0 | 22,200 |
Major Shareholders
| Holder | Shares | % of issued capital | Date / source |
|---|---|---|---|
Mercer Investments (Australia) Ltd (WSSP Australian Equities Trust; Mercer Australian Small Companies Fund) | 16,773,267 | 8.82 | Form 604, 29 Jun 2026 (up from 7.01%) |
Unnamed institutional holder (custodian JPMorgan Nominees Australia) | Sold below 5% | ceased | Form 605; ceased 28 Apr 2026 after selling ~3.6m shares on 21–28 Apr 2026 |
Haldon Industries Pty Ltd (Halpin-associated) | 5,100,000 | 2.7 | FY24 Annual Report (escrow to 15 Sep 2024); current holding not disclosed |
Seán Halpin (direct/other) | 1,000,000 | 0.5 | FY24 Annual Report; current not disclosed |
Simone Watt (former director) | 5,313,280 | 2.8 | FY24 Annual Report; current not disclosed |
Jon Gourlay | 1,371,551 | 0.7 | Market Index, notice 29 Apr 2026 |
Mike Utsler | 750,184 | 0.4 | Market Index, notice 14 May 2026 |
Dan O'Toole | 328,111 shares (plus 624,525 in a second disclosure column, likely rights) | 0.2 | Market Index, notice 1 May 2026 |
Johannes Risseeuw | 250,000 (column classification unclear) | 0.1 | Market Index, notice 29 Apr 2026 |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Relative positioning vs SciDev |
|---|---|---|---|
Process Chemistry (flocculants, mining) | SNF Group (France) | Private global polyacrylamide leader | Massive scale and integrated polymer production; SciDev competes on application service and feedstock via Nuoer |
Process Chemistry | Solenis (incl. ex-BASF flocculants business) | Private | Global mining reagents scale |
Process Chemistry | Kemira Oyj (Finland) | Listed | Water/process chemicals scale; Australian presence |
Process Chemistry / water treatment | Ecolab (Nalco Water) | Listed (US) | Dominant integrated water-treatment services |
Water Technologies (PFAS, D&C, BOO) | Veolia Water Technologies | Listed (France) | Global treatment engineering; large-project balance sheet |
Water Technologies (PFAS, Australia) | Specialist PFAS contractors (e.g., foam-fractionation and remediation firms) | Mostly private | Fragmented niche; SciDev claims a 40+ project track record |
Energy Services (friction reducers, clay control) | SLB (incl. ChampionX production chemicals) | Listed | Scale chemical provider |
Energy Services | Halliburton (Multi-Chem) | Listed | Integrated service company; potential customer and competitor |
Energy Services | Innospec (Oilfield Services segment) | Listed (US) | Specialty oilfield chemistry |
Energy Services | Flotek Industries | Listed (US) | Closest small-cap analogue in completion chemistry |
Energy Services | SNF / Kemira (friction-reducer polymers) | — | Commodity friction-reducer supply; driver of FY26 price competition |
Data-centre water | Veolia, Ecolab, engineering consultancies | — | SciDev's claim: early position with no established incumbent (company view) |
Peer Comparison FY2026
| Metric | SciDev (FY26) | Flotek (CY2024) | Innospec (CY2024) | Kemira (CY2024) |
|---|---|---|---|---|
Revenue | A$85.5m | ~US$187m | ~US$1.85bn | ~EUR 2.95bn |
Revenue growth | −17% | — | — | — |
EBITDA margin | 4.2% (underlying) | — | — | — |



